diagnostics in new waysnew places?

Copenhagen, August 2011 Concept and text: Birgitte Vedelstorp Andersen Layout: media-now.dk

Th is leafl et introduces Atolyzer diagnostics.

A multifunctional technology that is targeted at hospitals,clinics and surgeries. To ease the testing of patients and ensure thorough and comprehensive diagnostics, where patient and doctor meet. Central laboratory redefi ned. For prevention and early treatment.

One drop of blood from your fi ngertip. One small and portable analyzer. Single biomarker tests or several biomarkers in one.Result in less than fi fteen minutes.

Atolyzer diagnostics 2013.

Kind regardsAtonomics A/S

DOCTORS, PATIENTS, TREATMENT AND TECHNOLOGY 2013

22

3

WHAT

Atolyzer® is an all-round biomarker reader. One reusable instrument and a disposable biomarker cassette. In combination miniaturized in vitro diagnostics. Equal to central laboratory technology and in a few years an alternative choice for doctors.

First step is immunodiagnostics.

Heart marker tests such as Troponin I, CK-MB and BNP are already performing on prototype Atolyzer in laboratory trials.

Second step is molecular diagnostics.

Companion diagnostics and personalized medicine are fi rst focus.

Atolyzer is health technology at point of care for 21st century doctors.

4

5

HOW

colour touch screen, chemiluminescence, barcode, memory drive data exchange, PC connectivity, temperature control, LAN network, blood fi ltration, anticlustering technology, operator identifi cation, microfl uidics, micro magnetic beads, calibration, mechanics, electronics, nose swab, software, CPU, fl ash, patient record data base, chemistry, incubation, windows, washing, user interface, CV values, lot number, detection, self-contained cartridge, plasma, sensitivity, serum,millifl uidics, blood, no centrifugation, PMT, validation, algorithm, HIS, reference curve, LAMP, µl, quality control, NA purifi cation.

Point of care diagnostics is a means to prevent illness and detect diseases at an early stage.

Patient considerations require that new scientifi c and techno-logical knowledge are joined and put to work. Shorter gap between diagnosis and treatment is essential.

Health economics dictates low cost technology that off ers im-proved health services.

Across time and distance, in hot spots and surgeries or during home visits, doctors will need to better access the full health data of the individual patient. Better qualifi ed perscription,dosage, treatment and health guidance are benefi ts.

Atolyzer is one example that soon allows doctors to monitor patients fl exibly.

WHY

6

7

WHO

Atonomics A/SVestre Teglgade 10DK-2450 Copenhagen SVDenmark

Phone: +45 70271330Email: tw@atonomics.com

www.atonomics.comTwitter: atonomics

FOUNDED IN 2001 BYTh omas Warthoe, CEOLars Bangsgaard, CFOPeter Warthoe, CSO

PARTNERSInventages Venture Capital, Ltd. (Nestlé). Switzerland

Sunstone Capital. Denmark

Neurosearch A/S. Denmark

Founders. Denmark

Murata Manufacturing Co., Ltd. Japan

Beckman Coulter, Inc. USA

simply